There is mounting pressure for companies to ensure that non-essential personnel work from home. The challenge, of course, is to operate in a virtual capacity without sacrificing productivity – in particular for biotech companies engaging in drug discovery where timely access to data can make or break an organization.
The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation
Robert Roe looks back over the year at technology and processes driving trends in the laboratory
Sophia Ktori reveals the informatics company’s history – and plans for the future
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
